One in Four Oral Semaglutide Users Discontinue Due to GI Side Effects: Database Analysis
Oral semaglutide had a significant discontinuation rate due to adverse effects, predominantly gastrointestinal, with patterns and predictors characterized in a large database analysis.
Quick Facts
What This Study Found
Oral semaglutide: significant AE-related discontinuation predominantly due to GI effects (nausea, vomiting, diarrhea), with patient risk factors identified for predicting discontinuation.
Key Numbers
How They Did This
Database analysis of oral semaglutide discontinuation patterns, reasons (AE types), and predictive factors.
Why This Research Matters
Oral GLP-1 drugs are the future of metabolic medicine, but GI tolerability limits adherence. Understanding discontinuation patterns enables better patient management.
The Bigger Picture
GI tolerability remains the Achilles heel of GLP-1 drugs, whether injectable or oral. Solving this would dramatically improve real-world effectiveness.
What This Study Doesn't Tell Us
Database study. Cannot capture patients who tolerated side effects. Self-selected population.
Questions This Raises
- ?Could slower titration schedules reduce discontinuation?
- ?Would anti-nausea co-medication improve oral semaglutide tolerability?
- ?Are there genetic predictors of GI intolerance?
Trust & Context
- Key Stat:
- GI = main barrier Gastrointestinal side effects are the dominant reason patients stop oral semaglutide, with specific risk factors predicting who will discontinue
- Evidence Grade:
- Database analysis. Real-world tolerability data complementing clinical trial AE reporting.
- Study Age:
- Published in 2025.
- Original Title:
- Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.
- Published In:
- Diabetology international, 17(1), 14 (2026)
- Authors:
- Ishiguro, Mizuki, Nishimura, Rimei(2)
- Database ID:
- RPEP-15356
Evidence Hierarchy
Frequently Asked Questions
Do many people stop oral semaglutide due to side effects?
A significant proportion discontinue due to GI side effects — mainly nausea, vomiting, and diarrhea. Slow dose titration and taking the pill correctly can help minimize these effects.
How can I reduce nausea from oral semaglutide?
Take it on an empty stomach with a small sip of water, wait 30 minutes before eating, and ensure your doctor titrates the dose slowly. Some patients also benefit from anti-nausea strategies during the titration period.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15356APA
Ishiguro, Mizuki; Nishimura, Rimei. (2026). Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.. Diabetology international, 17(1), 14. https://doi.org/10.1007/s13340-025-00868-0
MLA
Ishiguro, Mizuki, et al. "Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.." Diabetology international, 2026. https://doi.org/10.1007/s13340-025-00868-0
RethinkPeptides
RethinkPeptides Research Database. "Discontinuation of oral semaglutide due to adverse effects: ..." RPEP-15356. Retrieved from https://rethinkpeptides.com/research/ishiguro-2026-discontinuation-of-oral-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.